Skip to main content
ISOP ACoP 2025 Annual Conference Main banner

General Pharmacometrics

(M-115) Dosage modifications in exposure-response analyses of oncology drug development: the brigimadlin case study

Monday, October 20, 2025
7:00 AM - 5:00 PM MDT
Location: Colorado A
Disclosure(s):
Jia Kang, PhD: No financial relationships to disclose